Press release
Rapid Increase in End-use Adoption to Boost Non Alcoholic Fatty Liver Disease Treatment Market Revenue Growth
Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-alcohol. Steatohepatitis can cause liver cirrhosis (fibrosis, scarring, and hardening of the liver). The cause of non-alcoholic fatty liver disease (NAFLD) is unknown. The nonalcoholic fatty liver disease (NAFLD) is one of the most common diseases in the United States. The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising due to rise in prevalence of diabetes and obesity. According to National Health and Nutrition Examination survey, about 20-30% of the general population in the western world suffer from nonalcoholic fatty liver disease (NAFLD). The common symptoms include fatigue, weakness, weight loss and others. The diagnosis of NAFLD requires the combination of different tests such as blood test, ultrasound, CT scan, MRI scan, and liver biopsy. The two types of Nonalcoholic fatty liver disease (NAFLD) includes simple fatty liver and Nonalcoholic Steatohepatitis (NASH). The simple fatty liver is a type of nonalcoholic fatty liver (NAFL), in which fat is deposited, but no inflammation or liver damage is observed. NASH is the inflammation of the liver due to excess fat deposit and can lead to liver damage and disease.In 2014, according to World Health Organization (WHO), estimate about ~422 Mn of the adult population was suffering from diabetes as compared to the ~108 Mn in 1980. The worldwide prevalence of diabetes is rising with the overall prevalence of 4.7% in 1980 to 8.5% in 2014. Therefore, rising prevalence of diabetes and obesity is a major factor contributing to revenue growth of nonalcoholic fatty liver disease treatment market across the globe. Availability of expanded product line as major market players in the global nonalcoholic fatty liver disease treatment market are introducing innovative and expanded line products to retain market share, expansion in clinical trials will lead to product approvals and revenue generation. Manufacturers and organizations such as National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institutes of Health (NIH) are involved research and development and are supporting research for various disease conditions. These are some of the factors boosting the growth of the nonalcoholic fatty liver disease treatment market
The global nonalcoholic fatty liver disease treatment market is segmented on basis of product type, end user and geography
Segment by Product Type,,Antioxidants,Thiazolidinedione,Biguanides,Lipid lowering Agents,FXR Receptor Agonist,Others,Segment by Distribution Channel,,Hospital Pharmacy,Retail Pharmacy,Drug Stores,Online Pharmacy,Others.
Global nonalcoholic fatty liver disease treatment market is segmented by product type and distribution channel. Based on the product type, the market is segmented into antioxidants, thiazolidinedione, biguanides, lipid lowering Agents, FXR receptor agonist and other medication used to treat nonalcoholic fatty liver disease. According to National Health and Nutrition Examination surveys conducted between 2009-2010, reported that prevalence of NASH is about 3% in general population in United States and about 25% in the obese individual. Thiazolidinedione and metformin are widely used for the Non-Alcoholic Liver Disease (NAFLD), thiazolidinedione and metformin are expected to gain higher share among other product types and will contribute in the revenue growth of global nonalcoholic fatty liver disease treatment market.
By Geography, the global nonalcoholic fatty liver disease treatment market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is estimated to lead the global nonalcoholic fatty liver disease treatment market due to increase in prevalence of diabetes and cardiovascular diseases in United States. Large number of manufacturers exist in the market, with large number of customer base. Asia Pacific market is also projected to experience high growth in the near future owing to factors such as, increase in healthcare expenditure, rising standard of living, lifestyle changes- attributed to better healthcare and awareness of the cost-effective treatment process with government grants and funding for acceleration in research and development activities.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/22498
Some of the major players in global nonalcoholic fatty liver disease treatment market Pfizer Inc., Hoffmann-La Roche Ltd., Daewoong Co., Ltd., Cardax, Inc., Merck & Co., Inc., Novartis AG, Gilead Sciences, Inc., AstraZeneca plc., Limerick BioPharma, Inc., GW Pharmaceuticals, Allergan, Plc., Takeda Pharmaceutical Company Ltd and others
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rapid Increase in End-use Adoption to Boost Non Alcoholic Fatty Liver Disease Treatment Market Revenue Growth here
News-ID: 1626097 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for NAFL
Major Government Initiatives helped the UAE Cold Chain Market Generate Over USD …
EXPO 2020 and Dubai Vision 2030 to help the UAE Cold Chain Market to grow at a CAGR of around 7% by 2025, as per the findings by Ken Research
1. Expo 2020 Dubai visit numbers have reached nearly 20 Mn - up almost 1.6 Mn in a week.
EXPO 2020: As UAE is to host the global mega event - EXPO 2020, national and international private investors are attracted not only…
Major Government Initiatives helped the UAE Cold Chain Market Generate Over USD …
EXPO 2020 and Dubai Vision 2030 to help the UAE Cold Chain Market to grow at a CAGR of around 7% by 2025, as per the findings by Ken Research
Other Challenges in Logistics Industry:
https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/uae-cold-chain-market-outlook-to-2025/515185-100.html
1. Expo 2020 Dubai visit numbers have reached nearly 20 Mn - up almost 1.6 Mn in a week.
EXPO 2020: As UAE is to host the global mega event - EXPO 2020, national and international private investors…
According to DelveInsight, the Non Alcoholic Fatty Liver Disease Market in 7MM i …
DelveInsight's "Non Alcoholic Fatty Liver Disease Market" report provides a thorough comprehension of the Non Alcoholic Fatty Liver Disease, historical and forecasted epidemiology, and the Non Alcoholic Fatty Liver Disease market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Non Alcoholic Fatty Liver Disease market report also proffers an analysis of the current Non Alcoholic Fatty Liver Disease treatment algorithm/practice,…
Non Alcoholic Fatty Liver Disease Treatment Market 2019 by Top Key Players:Pfize …
Market Study Report, LLC’s, latest study on Non Alcoholic Fatty Liver Disease Treatment Market features a holistic view of the market size, market share, profit estimates, SWOT analysis and the regional landscape of the business. The report precisely expounds key challenges and future growth prospects of the market, while highlighting the current competitive scene and analyzes the expansion strategies adopted by leading market players.
This report studies the Non Alcoholic Fatty…
Non Alcoholic Fatty Liver Disease Treatment Market Growth Trends, Key Players, C …
The report "Non Alcoholic Fatty Liver Disease Treatment Market - Global Industry Trend Analysis 2012 to 2016 and Forecast 2016 - 2025" gives complete assessment of the latest trends, challenges of market.
The objectives of this study are as follows:
• To define, describe, and forecast the "Non Alcoholic Fatty Liver Disease Treatment" market by type, application, component, delivery model, end user, and region
•…
FIATA, SCLG join Second Annual Middle East Logistics Awards as Industry Support …
Top logistics industry associations endorse MELA 2007 Awards
June 28, 2007, Dubai, UAE: As the nomination phase of the Second Annual Middle East Logistics Awards (MELA) 2007 is gaining momentum, some of the leading logistics bodies have announced their support for the prestigious event. International Federation of Freight Forwarders Associations (FIATA) and Supply Chain and Logistics Group (SCLG) have joined MELA as Industry Support Patrons. Manfred F Boes, President, FIATA,…